Anika Therapeutics (ANIK) Tops Q2 EPS by 35c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Crypto stocks rise premarket as Bitcoin hits over seven-month high
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- FortuneX and WT Realty announce $600M merger deal
Barrington Research Upgrades Anika Therapeutics (ANIk) to Outperform
July 27, 2018 8:29 AM EDTBarrington Research upgraded Anika Therapeutics (NASDAQ: ANIk) from Market Perform to Outperform.
For an analyst ratings summary and ratings history on Anika Therapeutics click here. For more ratings news on Anika Therapeutics click here.
Shares of Anika Therapeutics closed at $40.68 yesterday.
... More